Jia Xu

Jia Xu

Icahn School of Medicine at Mount Sinai

H-index: 16

North America-United States

About Jia Xu

Jia Xu, With an exceptional h-index of 16 and a recent h-index of 13 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of Cancer Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation

A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma

Novel Allosteric Inhibitor-Derived AKT Proteolysis Targeting Chimeras (PROTACs) Enable Potent and Selective AKT Degradation in KRAS/BRAF Mutant Cells

Abstract LB195: AKT degradation selectively inhibits the growth of PI3K/PTEN pathway mutant cancers with wild type KRAS and BRAF by destabilizing Aurora kinase B

Discovery of Potent, Selective, and In Vivo Efficacious AKT Kinase Protein Degraders via Structure–Activity Relationship Studies

AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B

Design, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders

Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway

Jia Xu Information

University

Position

___

Citations(all)

1064

Citations(since 2020)

496

Cited By

748

hIndex(all)

16

hIndex(since 2020)

13

i10Index(all)

16

i10Index(since 2020)

14

Email

University Profile Page

Icahn School of Medicine at Mount Sinai

Google Scholar

View Google Scholar Profile

Jia Xu Skills & Research Interests

Cancer Biology

Top articles of Jia Xu

Title

Journal

Author(s)

Publication Date

Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation

JCI insight

Karen Mendelson

Tiphaine C Martin

Christie B Nguyen

Min Hsu

Jia Xu

...

2024/3/22

A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma

Cancer Research

Royce Zhou

Jia Xu

Tiphaine Martin

Alexis Zachem

John He

...

2023/4/4

Novel Allosteric Inhibitor-Derived AKT Proteolysis Targeting Chimeras (PROTACs) Enable Potent and Selective AKT Degradation in KRAS/BRAF Mutant Cells

Journal of medicinal chemistry

Xufen Yu

Jia Xu

Kaitlyn M Cahuzac

Ling Xie

Yudao Shen

...

2022/10/5

Abstract LB195: AKT degradation selectively inhibits the growth of PI3K/PTEN pathway mutant cancers with wild type KRAS and BRAF by destabilizing Aurora kinase B

Cancer Research

Jia Xu

Xufen Yu

Tiphaine C Martin

Ankita Bansal

Kakit Cheung

...

2022/6/15

Discovery of Potent, Selective, and In Vivo Efficacious AKT Kinase Protein Degraders via Structure–Activity Relationship Studies

Journal of medicinal chemistry

Xufen Yu

Jia Xu

Yudao Shen

Kaitlyn M Cahuzac

Kwang-su Park

...

2022/2/4

AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B

Cancer discovery

Jia Xu

Xufen Yu

Tiphaine C Martin

Ankita Bansal

Kakit Cheung

...

2021/12/1

Design, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders

Journal of medicinal chemistry

Xufen Yu

Jia Xu

Ling Xie

Li Wang

Yudao Shen

...

2021/12/2

Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway

Journal of Experimental & Clinical Cancer Research

Jian Li

Danli Ye

Peng Shen

Xiaorong Liu

Peirong Zhou

...

2020/12

See List of Professors in Jia Xu University(Icahn School of Medicine at Mount Sinai)